Dyne Therapeutics, Inc.
DYN- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001818794
In the last 90 days, Dyne Therapeutics, Inc. insiders filed 0 open-market purchases and 10 sales; 245 institutions reported holding it in 13F filings for Q2 2026, worth $4.23B in total; no superinvestor holds it.
Superinvestors holding DYN, Q2 2026
No superinvestor reported holding DYN in Q2 2026.
Moves by quarter
Superinvestors that opened, added to, trimmed or sold out of DYN each quarter, comparing shares with the quarter before. A superinvestor that didn't file for a quarter isn't listed, and isn't counted as selling.
Q2 2023
0 superinvestors holding at quarter end
- Sold out
- HHLR Advisors (Hillhouse)
Q1 2023
1 superinvestor holding at quarter end
- Reduced
- HHLR Advisors (Hillhouse) (−49.1%)
Q4 2022
1 superinvestor holding at quarter end
- Reduced
- HHLR Advisors (Hillhouse) (−6.0%)